Best Investments/trading ideas for the weekJoin our free webinar on September23,2026.
Let's get started...
Best Investments/trading ideas for the weekJoin our free webinar on September23,2026.
Let's get started...
| Role | Insider | Date | Transaction | Value | Shares |
|---|---|---|---|---|---|
| CFO | Ogden Christopher | Jun 15, 2026 | Sell | $4.95K | 1,624 |
| SVP, Chief Scientific Officer | BELVIN MARCIA | Mar 17, 2026 | Sell | $202.27K | 31,492 |
| CFO | Ogden Christopher | Mar 17, 2026 | Sell | $124.11K | 19,323 |
| CEO | McCarthy Sean A. | Mar 17, 2026 | Sell | $764.14K | 118,969 |
| Chief Medical Officer | Chu Yu-Waye | Mar 17, 2026 | Sell | $136.68K | 21,279 |
| CEO | McCarthy Sean A. | Nov 6, 2025 | Sell | $461.91K | 101,793 |
| CEO | McCarthy Sean A. | Jun 16, 2025 | Sell | $149.26K | 55,511 |
| SVP, Chief Scientific Officer | BELVIN MARCIA | Jun 16, 2025 | Sell | $37.33K | 13,884 |
| CFO | Ogden Christopher | Jun 16, 2025 | Sell | $28.54K | 10,614 |
| CFO | Ogden Christopher | Jun 13, 2025 | Sell | $4.84K | 1,641 |
| SVP, Chief Scientific Officer | BELVIN MARCIA | Mar 18, 2025 | Sell | $11.69K | 19,512 |
| General Counsel | ROWLAND LLOYD A | Mar 18, 2025 | Sell | $6.11K | 10,203 |
| Chief Medical Officer | Chu Yu-Waye | Mar 18, 2025 | Sell | $2.41K | 4,025 |
| CFO | Ogden Christopher | Mar 18, 2025 | Sell | $5.12K | 8,551 |
| CEO | McCarthy Sean A. | Mar 18, 2025 | Sell | $22.56K | 37,656 |
| CEO | McCarthy Sean A. | Aug 20, 2024 | Sell | $17.08K | 13,898 |
| SVP, Chief Scientific Officer | BELVIN MARCIA | Aug 20, 2024 | Sell | $5.14K | 4,181 |
| General Counsel | ROWLAND LLOYD A | Aug 20, 2024 | Sell | $5.14K | 4,181 |
| Chief Business Officer | Landau Jeffrey B | Aug 20, 2024 | Sell | $5.14K | 4,181 |
| CFO | Ogden Christopher | Aug 20, 2024 | Sell | $2.44K | 1,984 |
| Chief Business Officer | Landau Jeffrey B | Mar 19, 2024 | Sell | $13.69K | 6,562 |
| CEO | McCarthy Sean A. | Mar 19, 2024 | Sell | $42.18K | 20,223 |
| SVP, Chief Scientific Officer | BELVIN MARCIA | Mar 19, 2024 | Sell | $26.68K | 12,795 |
| SVP, Finance and Accounting | Ogden Christopher | Mar 19, 2024 | Sell | $6.2K | 2,971 |
| General Counsel | ROWLAND LLOYD A | Mar 19, 2024 | Sell | $10.99K | 5,268 |
Open-market purchases and sales reported on SEC form 4 over the last 10years. Awards, option exercises, gifts and other non-market form 4 activity are excluded. Chart markers group a day's filings by direction; the table lists each filing.